Advertisement

Pharmacy

CMS proposed several changes for the third round of Medicare drug price negotiations, including the potential inclusion of some drugs under Medicare Part B, in a draft guidance published May 12. The guidance aims to increase program transparency, prioritize the…

President Donald Trump signed an executive order May 12 directing drugmakers to sell medicines in the U.S. at prices similar to those offered in other wealthy countries, or face penalties and enforcement actions.  The move tasks HHS Secretary Robert F.…

In a 160-page bill introduced May 11, House Republicans proposed requiring pharmacy benefit managers to adhere to a transparent pass-through pricing model with states.  If the bill — which aims to cut billions of dollars in Medicaid funds — passes,…

As several health systems work toward a shared goal of reducing greenhouse gas emissions by 50% by 2030, some are rolling out sustainability efforts in their pharmacy departments.  Charlottesville, Va.-based UVA Health introduced recyclable pill bottles in April. The containers…

Advertisement

The latest USP <797> chapter revisions, released in November 2023, require hospital-based compounding pharmacies to implement more stringent workflows and commit resources to comply with new standards, including: While many health systems have taken steps to address these new standards,…

An experimental cell therapy developed at the University of Wisconsin Health in Madison has received the FDA’s fast-track designation.  The treatment, developed through a partnership between UW Health and the UW School of Medicine and Public Health, is designed to…

Walgreens is expanding its use of robotic micro fulfillment centers to handle prescription volume as part of a renewed push to streamline pharmacy operations and address staffing challenges, CNBC reported May 11. The company told the news outlet it plans…

Moderna’s new combination vaccine for seasonal influenza and COVID-19 has outperformed current standard vaccines in a large phase 3 clinical trial, showing stronger immune responses to both viruses in adults 50 years or older.  The findings, published May 7 in…

A new fixed-dose combination therapy pairing obicetrapib with the cholesterol-lowering drug ezetimibe significantly reduced low-density lipoprotein (LDL) cholesterol levels in patients whose cholesterol remained elevated despite statin use, according to research published in The Lancet. The randomized, double-blind study enrolled…

Advertisement